Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Engineering · 2023-09 · 28 · 193-205
DOI: 10.1016/j.eng.2023.04.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Engineering, 2023-09. Verfasst von Chuanqi Chu und 10 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Chu, C., Jiang, J., Yu, L., Li, Y., Zhang, S., Zhou, W., Wang, Q., Zhao, J., Zhai, Q., Tian, F., & Chen, W. (2023). Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Engineering, 28, 193-205. https://doi.org/10.1016/j.eng.2023.04.010
Vancouver
Chu C, Jiang J, Yu L, Li Y, Zhang S, Zhou W, et al. Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Engineering. 2023;28:193-205. doi:10.1016/j.eng.2023.04.010
BibTeX
@article{Chu2023,
author = {Chu, Chuanqi and Jiang, Jinchi and Yu, Leilei and Li, Yiwen and Zhang, Songli and Zhou, Wei and Wang, Qun and Zhao, Jianxin and Zhai, Qixiao and Tian, Fengwei and Chen, Wei},
title = {Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial},
journal = {Engineering},
year = {2023},
volume = {28},
pages = {193--205},
doi = {10.1016/j.eng.2023.04.010}
}
EUVIMED